Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased… Grant US-11541047-B2 United States of America 03 Jan 2023
Synergistic effect of anti-trop-2 antibody-drug conjugate in combination therapy for… Grant US-11439620-B2 United States of America 13 Sep 2022
Combining anti-HLA-DR or anti-Trop-2 antibodies with microtubule inhibitors, PARP… Grant US-11253606-B2 United States of America 22 Feb 2022
Immunoconjugates with an intracellularly-cleavable linkage Grant US-11066468-B2 United States of America 20 Jul 2021
Combination therapy with anti-HLA-DR antibodies and kinase inhibitors in hematopoietic… Grant US-10988539-B2 United States of America 27 Apr 2021
Combination of ABCG2 inhibitors with sacituzumab govitecan (IMMU-132) overcomes… Grant US-10954305-B2 United States of America 23 Mar 2021
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased… Grant US-10918721-B2 United States of America 16 Feb 2021
Treatment of high Trop-2 expressing triple negative breast cancer (TNBC) with sacituzumab… Grant US-10918734-B2 United States of America 16 Feb 2021
Efficacy of anti-HLA-DR antibody drug conjugate IMMU-140 (hL243-CL2A-SN-38) in HLA-DR… Grant US-10709701-B2 United States of America 14 Jul 2020
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased… Grant US-10682347-B2 United States of America 16 Jun 2020
Isolation, detection, diagnosis and/or characterization of circulating Trop-2-positive… Grant US-10436788-B2 United States of America 08 Oct 2019
Immunoconjugates with an intracellularly-cleavable linkage Grant US-10280220-B2 United States of America 07 May 2019
Efficacy of anti-HLA-DR antiboddy drug conjugate IMMU-140 (hL243-CL2A-SN-38) in HLA-DR… Grant US-10206918-B2 United States of America 19 Feb 2019
Synergistic effect of anti-Trop-2 antibody-drug conjugate in combination therapy for… Grant US-10195175-B2 United States of America 05 Feb 2019
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased… Grant US-10137196-B2 United States of America 27 Nov 2018
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased… Grant US-10130626-B2 United States of America 20 Nov 2018
Combination therapy with anti-HLA-DR antibodies and kinase inhibitors in hematopoietic… Grant US-10058621-B2 United States of America 28 Aug 2018
Isolation, detection, diagnosis and/or characterization of circulating Trop-2-positive… Grant US-9797907-B2 United States of America 24 Oct 2017
Anti-Trop-2 antibody-drug conjugates and uses thereof Grant US-9770517-B2 United States of America 26 Sep 2017
Combining anti-HLA-DR or anti-Trop-2 antibodies with microtubule inhibitors, PARP… Grant US-9707302-B2 United States of America 18 Jul 2017
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased… Grant US-9493573-B2 United States of America 15 Nov 2016